Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | IVX037 |
| Synonyms | |
| Therapy Description |
IVX037 is an oncolytic RNA virus that selectively infects tumor cells by targeting tumor-specific receptors, potentially leading to induction of cytotoxicity and tumor cell death (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| IVX037 | IVX-037|IVX 037 | IVX037 is an oncolytic RNA virus that selectively infects tumor cells by targeting tumor-specific receptors, potentially leading to induction of cytotoxicity and tumor cell death (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05427487 | Phase I | IVX037 IVX037 + Sintilimab | Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours | Recruiting | AUS | 0 |